A series of 5-substituted-2-(dimethylaminomethyl)-furyl derivatives 4
was prepared, with the aim of discovering novel antimuscarinic agents
which are selective for smooth muscle as opposed to cardiac tissue. Bo
th non-quaternary and quaternary ammonium compounds were synthesised.
The agonist starting point, furtrethonium 3, was gradually transformed
into antagonist by introduction of lipophilic and bulky groups in pos
ition 5 of this molecule. In particular, the introduction of alpha-hyd
roxy-alpha-cyclohexylbenzyl moiety (compound 9b), a lipophilic group c
haracteristic of antimuscarinic agents, caused an appreciable increase
of the antagonist's potency, and the lengthening of the distance betw
een this lipophilic group and the furan ring, obtained by introduction
of an ester, ether or amide group, led to some selectivity towards sm
ooth muscle (compounds 19, 21, 25). Interestingly, compound 19, with a
n ester moiety as a spacer group, proved to be at least 20 times more
potent in rat ileum (pK(B) = 7.3) and rat bladder (pK(B) = 7.2) than g
uinea-pig atria (pK(B) = 5.9).